SUNC Q1 2026 Earnings Significant Earnings Miss Amid Challenging Quarter Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech MTX Q1 2026 Earnings EPS Surpasses Estimates by 887 Amid Solid Operational Performance CRS Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Demand in Aerospace and Defense Via Transportation Inc VIA Q1 2026 Earnings Narrower Loss Beats Estimates Amid Strategic Shift FAF Q1 2026 Earnings EPS Beat by 256 Despite Mixed Market Reaction